Saarbrücken, Germany

Arianna Castoldi


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Arianna Castoldi: Innovator in Intracellular Drug Targeting

Introduction

Arianna Castoldi, based in Saarbrücken, Germany, is an accomplished inventor whose work focuses on the development of advanced carrier systems for drug targeting. With a passion for pharmaceuticals and innovative solutions, she has made significant contributions to the field of medicine through her groundbreaking research.

Latest Patents

Arianna Castoldi holds a notable patent titled "Methods and compositions of carrier systems for the purpose of intracellular drug targeting." This invention describes a carrier system that includes a pathogen entry protein or its fragment, specifically designed to bind to molecules on the surface of mammalian target cells. The carrier is covalently linked to the surface of the system and includes at least one hydrophilic antipathogenic agent. Additionally, the patent outlines a method for manufacturing the carrier system, as well as the application of the pharmaceutical composition as a medicament.

Career Highlights

Arianna is part of the Helmholtz-Zentrum für Infektionsforschung GmbH, where she conducts research that pushes the boundaries of traditional drug delivery methods. Her patent reflects her commitment to enhancing the efficacy of treatments and addressing challenges in intracellular targeting.

Collaborations

Throughout her career, Arianna has collaborated with esteemed colleagues such as Claus-Michael Lehr and Hagar Ibrahim Labouta. These partnerships have enabled her to merge diverse expertise and drive innovative solutions in the field of pharmaceutical sciences.

Conclusion

Arianna Castoldi is a remarkable inventor, making strides in the realm of intracellular drug targeting through her innovative patent. Her contributions at the Helmholtz-Zentrum für Infektionsforschung GmbH and collaborations with talented colleagues underpin her commitment to advancing medical technologies for better health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…